Will $1.7M NCI Grant Make NimbleGen More Competitive in ChIP-on-chip Market? | GenomeWeb

NimbleGen last week was awarded a $1.7 million, four-year grant from the National Cancer Institute to map regulatory pathways in cancer in collaboration with the Ludwig Institute for Cancer Research and Iceland Genomics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.